DS
ALXN

DRW Securities’s Alexion Pharmaceuticals ALXN Stock Holding History

DRW Securities’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,110
Closed -$204K – 397
2021
Q2 		$204K Buy
+1,110
New +$191K 0.01% 283
2020
Q1 		– Sell
-3,108
Closed -$336K – 398
2019
Q4 		$336K Buy
+3,108
New +$332K 0.01% 158
2018
Q1 		– Sell
-3,120
Closed -$373K – 509
2017
Q4 		$373K Buy
3,120
+420
+16% +$51.1K 0.04% 270
2017
Q3 		$379K Buy
2,700
+900
+50% +$122K 0.12% 34
2017
Q2 		$219K Buy
+1,800
New +$209K 0.04% 56
2014
Q3 		– Sell
-32,503
Closed -$5.08M – 146
2014
Q2 		$5.08M Buy
+32,503
New +$5.13M 0.93% 17

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return